INTECH Investment Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$213K Sell
37,418
-7,220
-16% -$31.2K ﹤0.01% 1765
2026
Q1
$173K Sell
44,638
-18,380
-29% -$75.4K ﹤0.01% 1791
2025
Q4
$263K Buy
63,018
+3,137
+5% +$12.1K ﹤0.01% 1826
2025
Q3
$197K Sell
59,881
-10,022
-14% -$28.3K ﹤0.01% 2074
2025
Q2
$99.3K Sell
69,903
-48,006
-41% -$68.2K ﹤0.01% 2298
2025
Q1
$176K Buy
+117,909
New +$186K ﹤0.01% 2142

Other funds holding PGEN

INTECH Investment Management's PGEN Position: Q2 2026 in Review

INTECH Investment Management reduced its Precigen (PGEN) stake by 16% in Q2 2026, selling an estimated $31.2K and leaving 37,418 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #1765.

INTECH Investment Management first reported a position in PGEN in Q1 2025 and has held it in 6 quarters since. The position peaked at $263K in Q4 2025. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • INTECH Investment Management held 37,418 shares of Precigen worth $213K as of Q2 2026.
  • INTECH Investment Management sold 7,220 Precigen shares in Q2 2026, an estimated $31.2K.
  • Precigen made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1765 holding.
  • INTECH Investment Management first reported a position in Precigen in Q1 2025 and has held it in 6 quarters since.
  • INTECH Investment Management's Precigen position peaked at $263K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.